Biogen licenses a possible immune drug from OrbiMed-backed biotech
Biogen Licenses Immune Drug from Vanqua Bio Biogen has licensed a preclinical immune drug from Vanqua Bio, a biotech company backed by OrbiMed, in a deal worth over $1 billion. The …
Biogen Licenses Immune Drug from Vanqua Bio Biogen has licensed a preclinical immune drug from Vanqua Bio, a biotech company backed by OrbiMed, in a deal worth over $1 billion. The …
Early Voting on Long Island Early voting is set to commence on Saturday across Long Island in anticipation of Election Day 2025. Vo…
Iowa Officials Accused of "Sweetheart Deal" with Meatpacker An environmental group alleges that Iowa officials secretly fast-tracked a leg…
Joyce Bawah Mogtari Pays Tribute to Nana Konadu Agyemang Rawlings Senior Presidential Aide Joyce Bawah Mogtari has paid tribute to the lat…
Wisconsin Supreme Court Justice Recusal Wisconsin Supreme Court Justice Susan Crawford will not participate in the upcoming disciplinary p…
Early Voting Begins Saturday Early voting for the 2025 election starts on Saturday. To find voting locations in your area, visit the state…
Pharmaceutical Executive Daily: TrumpRx's Implication on DTC Commercialization Welcome to Pharmaceutical Executive Daily, your quick brief…
The Future Of Web Development In Los Angeles Web development in LA has become a defining force in the digital economy, shaping how busines…
US Visa Sanction Reversal for Ghana Majority Leader Mahama Ayariga commended Foreign Affairs Minister Samuel Okudzeto Ablakwa for securing…
Nothing Adds Bloatware to Phones for Revenue Nothing started rolling out the first Nothing OS 4.0 beta build to its Phone 3a series, but u…
Trump's Dispute with Canada Over Tariffs President Donald Trump ended trade talks with Canada due to a Canadian ad that he claimed misstat…